As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
SAPA-NE 26th Annual Conference
Pioneer New Era of Pharmaceutical Industry with Innovation of Emerging Modality
The Annual Conference comprises a full-day program (9 am - 5 pm, June 8th) focusing on multi-front industry topics including rare diseases, drug development, commercial readiness, regulatory landscape, and other trends in the ever-evolving life science industry in the Greater Boston/Cambridge region.
Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. As of April 2024, Medicilon has proudly served over 2000 clients worldwide, contributing to the successful approval of over 400 IND applications in China and over 70 INDs overseas, demonstrating our commitment to providing high-quality services and supporting the global advancement of pharmaceutical development.
❖20 Years of Excellence
❖480 IND Approved by FDA, NMPA, EMA, and TGA
❖2000+ Active Clients Worldwide
❖2600+ Scientists & Research Staff
❖85,000+ m2 Lab Space
At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China.
Date: Saturday, June 8th, 2024, 9 AM – 5 PM EDT
Location: Boston Marriott Cambridge (50 Broadway, Cambridge, MA 02142)